Domiciliary Versus Hospital Management of PPROM
PPROM
Planned Domiciliary Versus Hospital Care for Women With Preterm Prelabor Rupture of the Membranes (PPROM)
1 other identifier
observational
3,662
1 country
1
Brief Summary
This study is designed to compare efficacy \& safety of planned domiciliary versus hospital care for women with preterm prelabor rupture of the membranes (PPROM) on fetal, neonatal and maternal outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedFirst Submitted
Initial submission to the registry
May 29, 2020
CompletedFirst Posted
Study publicly available on registry
June 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2020
CompletedJanuary 6, 2021
January 1, 2021
1.5 years
May 29, 2020
January 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Take-home baby
this outcome is the best indicator of success of the management plan when the outcome is alive \& well baby
2 years
Study Arms (2)
Group (D): Planned domiciliary care.
Patients within this group will be counseled for home care with self-monitoring for any symptoms suggestive of preterm labor, maternal or fetal distress.
Group (H): Planned hospital care.
Patients within this group will be admitted at hospital for close monitoring of maternal \& fetal wellbeing \& finally the neonatal outcome
Interventions
Patients recruited in this study commenced antibiotic treatment according to the recent guidelines : * Erythromycin 250 mg 4 times daily for 10 days following the diagnosis of PPROM, or until the women is established labor (whichever sooner) * Penicillin may be used in patients who can't tolerate erythromycin * In cases of penicillin allergy: Cefazolin 1 g intravenously every 8 hours for 48 hours, followed by cephalexin 500 mg orally four times daily for five days. These drugs provide coverage for both GBS and Escherichia coli, the two major causes of neonatal infection.
Eligibility Criteria
The study will include 3662 women with a history of preterm prelabor rupture of the membranes
You may not qualify if:
- Query PPROM: A history of PPROM with no pooling of amniotic fluid from the cervix on a sterile speculum examination
- Maternal comorbidities (Diabetes mellitus, hypertension, etc.)
- Patients with placenta previa
- Amniotic fluid pocket on ultrasound \< 2x2 cm
- Logistic problems interfering with follow-up
- Inability to check temperature every six hours, with parameters for notifying their clinician (temperature ≥38°C)
- Non-Dependable transportation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine - Ain Shams university
Cairo, 11517, Egypt
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- ASelim
Study Record Dates
First Submitted
May 29, 2020
First Posted
June 2, 2020
Study Start
April 15, 2019
Primary Completion
October 1, 2020
Study Completion
October 20, 2020
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- onset of January, 2022 (6 months after publication)
- Access Criteria
- sponsor e.mail \& the sponsor organisation
all statistical methods, results of the study ,discussion \& recommendations